Answers are grounded in this paper and cite their sources.
Introduction: There is no consensus on induction therapy in heart transplantation, although interleukin-2 receptor blockers (basiliximab), thymoglobulin, and steroids are used. In Mexico, there is no experience in the use of thymoglobulin as an induction in heart transplantation. We compared thymoglobulin and basiliximab as inducers of immunosuppression in heart transplantation.
No takes yet. Share an insight, caveat, or question.
Zetina-Tun et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: